KIAA1429 is not only potentially related to immunity but is also an upstream gene of the key glycolytic enzyme HK2, which enhances the stability of HK2 in an m6A‐dependent manner, thereby promoting tumor glycolysis [41]. The gene discussed is HK1; the disease is neoplasm.